Medical Plastics News group editor Dave Gray recently spoke to Michael Faulkner, president of BMP medical to discuss the new plastics manufacturing facility.
Earlier this year, BMP Medical announced the opening of its new medical plastics manufacturing facility. Michael Faulkner, president of BMP medical stated that the new location Sterling, Massachusetts was chosen for several reasons, including its close proximity to the previous location in Gardner, Massachusetts. In Faulkner’s words this makes the new location, “optimal for our long-tenured and experienced workforce.”
The plastic contract manufacturing facility will aim to serve as a hub for making BMP Medical’s full range of manufacturing services available to the growing medical device and diagnostic manufacturing Original Equipment Manufacturers (OEMs) marketplace.
“Our founder first established several businesses in Leominster, Massachusetts which is also known as the Pioneer Plastics City”, Faulkner highlighted. “The 80,000 square foot building also had pre-existing injection moulding infrastructure and was an ideal setup for our manufacturing equipment.”
The new facility will accommodate, “plastic medical device injection moulding contract manufacturing services to leading OEMs for class 1 medical devices, exclusively serving the medical device industry.
“Our capabilities include class 8 clean room injection moulding, injection blow moulding, 2-shot moulding, insert moulding, finish goods assembly & packaging.”
Faulkner mentioned how the site would be opened for tours for potential medical and diagnostic OEM manufacturing partners throughout 2019.
Prior to the move, investments were made which Faulkner stated included a, “new glycol based chiller system, an upgraded material handling system, a new heating, ventilation and air conditioning system, upgraded electric panels and wiring, 3 new all electric presses and additional robotics.”
With regards to new future expansions, Faulkner said, “this new facility allows for our forecasted business growth. We will be able to allocate more assembly, packaging, and cleanroom space for further product life-cycle support. Designs are in place for increasing manufacturing capacity which will accommodate an additional 14 -16 machines.”
Faulkner mentioned how, “OEMs require greater quality control over their supply chains” and this can be challenging.
“Our commitment to MedAccred, a robust program managed by the MedTech industry, provides supply chain oversight via standardised audit criteria and is helping to address OEMs concerns.
“Some of the leading OEMs have participated in helping to develop this specific criterion. BMP Medical is the first injection moulding company to achieve accreditation from MedAccred.”
Faulkner concluded with, “BMP Medical’s robust quality systems reduce overall risk for OEMs through an entire product life cycle.”